147 related articles for article (PubMed ID: 30222982)
1. Development of a novel progesterone analog in the treatment of traumatic brain injury.
Sayeed I; Wali B; Guthrie DB; Saindane MT; Natchus MG; Liotta DC; Stein DG
Neuropharmacology; 2019 Feb; 145(Pt B):292-298. PubMed ID: 30222982
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the neurotherapeutic potential of a water-soluble progesterone analog after traumatic brain injury in rats.
Wali B; Sayeed I; Guthrie DB; Natchus MG; Turan N; Liotta DC; Stein DG
Neuropharmacology; 2016 Oct; 109():148-158. PubMed ID: 27267687
[TBL] [Abstract][Full Text] [Related]
3. Progesterone Provides the Pleiotropic Neuroprotective Effect on Traumatic Brain Injury Through the Nrf2/ARE Signaling Pathway.
Zhang M; Wu J; Ding H; Wu W; Xiao G
Neurocrit Care; 2017 Apr; 26(2):292-300. PubMed ID: 27995513
[TBL] [Abstract][Full Text] [Related]
4. Repurposing and repositioning neurosteroids in the treatment of traumatic brain injury: A report from the trenches.
Stein DG; Sayeed I
Neuropharmacology; 2019 Mar; 147():66-73. PubMed ID: 29630902
[TBL] [Abstract][Full Text] [Related]
5. Progesterone neuroprotection: The background of clinical trial failure.
Schumacher M; Denier C; Oudinet JP; Adams D; Guennoun R
J Steroid Biochem Mol Biol; 2016 Jun; 160():53-66. PubMed ID: 26598278
[TBL] [Abstract][Full Text] [Related]
6. Progesterone in the clinical treatment of acute traumatic brain injury.
Stein DG; Wright DW
Expert Opin Investig Drugs; 2010 Jul; 19(7):847-57. PubMed ID: 20486864
[TBL] [Abstract][Full Text] [Related]
7. Progesterone treatment improves cognitive outcome following experimental traumatic brain injury in rats.
Si D; Wang H; Wang Q; Zhang C; Sun J; Wang Z; Zhang Z; Zhang Y
Neurosci Lett; 2013 Oct; 553():18-23. PubMed ID: 23954829
[TBL] [Abstract][Full Text] [Related]
8. Intralipid Vehicle Does Not Interfere with the Efficacy of Progesterone in Attenuating Edema following Traumatic Brain Injury.
Wali B; Stein DG; Sayeed I
J Neurotrauma; 2017 Jul; 34(13):2183-2186. PubMed ID: 28075214
[TBL] [Abstract][Full Text] [Related]
9. External Validation of the International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury: Prognostic Models for Traumatic Brain Injury on the Study of the Neuroprotective Activity of Progesterone in Severe Traumatic Brain Injuries Trial.
Sun H; Lingsma HF; Steyerberg EW; Maas AI
J Neurotrauma; 2016 Aug; 33(16):1535-43. PubMed ID: 26652051
[TBL] [Abstract][Full Text] [Related]
10. A review of the neuroprotective role of vitamin D in traumatic brain injury with implications for supplementation post-concussion.
Lawrence DW; Sharma B
Brain Inj; 2016; 30(8):960-8. PubMed ID: 27185224
[TBL] [Abstract][Full Text] [Related]
11. Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.
Blaya MO; Wasserman JM; Pieper AA; Sick TJ; Bramlett HM; Dietrich WD
Neuropharmacology; 2019 Feb; 145(Pt B):268-282. PubMed ID: 30236963
[TBL] [Abstract][Full Text] [Related]
12. Progesterone Exacerbates Short-Term Effects of Traumatic Brain Injury on Supragranular Responses in Sensory Cortex and Over-Excites Infragranular Responses in the Long Term.
Allitt BJ; Johnstone VP; Richards K; Yan EB; Rajan R
J Neurotrauma; 2016 Feb; 33(4):375-89. PubMed ID: 26258958
[TBL] [Abstract][Full Text] [Related]
13. Suboptimal Dosing Parameters as Possible Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain Injury.
Howard RB; Sayeed I; Stein DG
J Neurotrauma; 2017 Jun; 34(11):1915-1918. PubMed ID: 26370183
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial specific therapeutic targets following brain injury.
Yonutas HM; Vekaria HJ; Sullivan PG
Brain Res; 2016 Jun; 1640(Pt A):77-93. PubMed ID: 26872596
[TBL] [Abstract][Full Text] [Related]
15. Effects of Female Sex Steroids Administration on Pathophysiologic Mechanisms in Traumatic Brain Injury.
Khaksari M; Soltani Z; Shahrokhi N
Transl Stroke Res; 2018 Aug; 9(4):393-416. PubMed ID: 29151229
[TBL] [Abstract][Full Text] [Related]
16. The enantiomer of progesterone acts as a molecular neuroprotectant after traumatic brain injury.
VanLandingham JW; Cutler SM; Virmani S; Hoffman SW; Covey DF; Krishnan K; Hammes SR; Jamnongjit M; Stein DG
Neuropharmacology; 2006 Nov; 51(6):1078-85. PubMed ID: 16926035
[TBL] [Abstract][Full Text] [Related]
17. A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury?
Stein DG
Horm Behav; 2013 Feb; 63(2):291-300. PubMed ID: 22626570
[TBL] [Abstract][Full Text] [Related]
18. Combination of drug and stem cells neurotherapy: Potential interventions in neurotrauma and traumatic brain injury.
Zibara K; Ballout N; Mondello S; Karnib N; Ramadan N; Omais S; Nabbouh A; Caliz D; Clavijo A; Hu Z; Ghanem N; Gajavelli S; Kobeissy F
Neuropharmacology; 2019 Feb; 145(Pt B):177-198. PubMed ID: 30267729
[TBL] [Abstract][Full Text] [Related]
19. Natural Compounds as a Therapeutic Intervention following Traumatic Brain Injury: The Role of Phytochemicals.
Scheff SW; Ansari MA
J Neurotrauma; 2017 Apr; 34(8):1491-1510. PubMed ID: 27846772
[TBL] [Abstract][Full Text] [Related]
20. Neurotherapeutic Potential of Water-Soluble pH-Responsive Prodrugs of EIDD-036 in Traumatic Brain Injury.
Fritzemeier RG; van der Westhuyzen AE; D'Erasmo M; Sharma SK; Bartsch P; Hodson LE; Liu K; Wali B; Sayeed I; Liotta DC
J Med Chem; 2023 Apr; 66(8):5397-5414. PubMed ID: 37026870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
